Tobias receives career development grant

The University of Arizona Health Sciences Career Development Awards program recently selected Tobias as one of its five 2023 recipients.

Our lab will investigate the potential of this circRNA as a signature molecule, or a biomarker, which can be used to help physicians monitor the presence or progression of atrial fibrillation from a single blood sample. This new circRNA-based biomarker may provide us with a non-invasive and efficient way to detect atrial fibrillation early and potentially develop personalized therapies tailored to an individual’s unique genetic profile.